Prognostic factors in esophageal cancer treated with curative intent

被引：34
作者：
Vendrely, Veronique [1 ,2 ,3 ]
Launay, Vincent [4 ]
Najah, Haythem [4 ]
Smith, Denis [5 ]
Collet, Denis [1 ,4 ]
Gronnier, Caroline [1 ,4 ,6 ]
机构：
[1] Bordeaux Univ Med, Bordeaux, France
[2] Haut Leveque Hosp, Dept Radiat Oncol, Pessac, France
[3] INSERM UMR1035 Univ Bordeaux, Bordeaux, France
[4] Bordeaux Univ Hosp, Magellan Ctr, Visceral Surg Dept, Esophageal & Endocrine Surg Unit, F-33600 Pessac, France
[5] Bordeaux Univ Hosp, Magellan Ctr, Dept Hepatogastroenterol, Pessac, France
[6] Univ Bordeaux, BaRITOn, INSERM, Bordeaux Res Translat Oncol UMR1053, Bordeaux, France
来源：
DIGESTIVE AND LIVER DISEASE | 2018年 / 50卷 / 10期
关键词：
Chemoradiotherapy; Chemotherapy; Esophageal cancer; Prognosis; Surgery; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; SQUAMOUS-CELL CARCINOMA; NEOADJUVANT TREATMENT; PARENTERAL-NUTRITION; ENTERAL NUTRITION; PREDICTS SURVIVAL; LYMPH-NODES; IMPACT; SURGERY; CHEMORADIOTHERAPY;
D O I：
10.1016/j.dld.2018.08.002
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The overall prognosis of patients with esophageal cancer has improved in recent decades due to surgical and medical progress, but overall survival remains poor. Better patient selection and tailored treatment are needed. Different prognostic factors linked with the patient, tumoral characteristics and treatment with curative intent have been identified and are the purpose of this review. Tumor detection at an earlier stage, the advent of new molecules and therapeutic combinations, and the centralization of management in high-volume centers should help to improve the prognosis of esophageal cancer. Improved imaging techniques and a better prediction strategy should guide future treatments. (c) 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：991 / 996
页数：6
相关论文
共 68 条
[21]   Preoperative imaging and prediction of oesophageal conduit necrosis after oesophagectomy for cancer [J].
Lainas, P. ;
Fuks, D. ;
Gaujoux, S. ;
Machroub, Z. ;
Fregeville, A. ;
Perniceni, T. ;
Mal, F. ;
Dousset, B. ;
Gayet, B. .
BRITISH JOURNAL OF SURGERY, 2017, 104 (10) :1346-1354
[22]   Factors predictive of prognosis after esophagectomy for squamous cell cancer [J].
Li, Houhuai ;
Zhang, Qingzhen ;
Xu, Lin ;
Chen, Yijiang ;
Wei, Yongxiang ;
Zhou, Guoren .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 137 (01) :55-59
[23]   Grains or veins: Is enteral nutrition really better than parenteral nutrition? A look at the evidence [J].
Lipman, TO .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1998, 22 (03) :167-182
[24]   Benchmarking Complications Associated With Esophagectomy [J].
Low, Donald E. ;
Kuppusamy, Madhan Kumar ;
Alderson, Derek ;
Cecconello, Ivan ;
Chang, Andrew C. ;
Darling, Gail ;
Davies, Andrew ;
D'Journo, Xavier Benoit ;
Gisbertz, Suzanne S. ;
Griffin, S. Michael ;
Hardwick, Richard ;
Hoelscher, Arnulf ;
Hofstetter, Wayne ;
Jobe, Blair ;
Kitagawa, Yuko ;
Law, Simon ;
Mariette, Christophe ;
Maynard, Nick ;
Morse, Christopher R. ;
Nafteux, Philippe ;
Pera, Manuel ;
Pramesh, C. S. ;
Puig, Sonia ;
Reynolds, John V. ;
Schroeder, Wolfgang ;
Smithers, Mark ;
Wijnhoven, B. P. L. .
ANNALS OF SURGERY, 2019, 269 (02) :291-298
[25]   Percutaneous endoscopic gastrostomy before multimodality therapy in patients with esophageal cancer [J].
Margolis, M ;
Alexander, P ;
Trachiotis, GD ;
Gharagozloo, F ;
Lipman, T .
ANNALS OF THORACIC SURGERY, 2003, 76 (05) :1694-1697
[26]   Perioperative care in digestive surgery [J].
Mariette, C ;
Alves, A ;
Benoist, S ;
Bretagnol, F ;
Mabrut, JY ;
Slim, K .
JOURNAL DE CHIRURGIE, 2005, 142 (01) :14-28
[27]   The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent [J].
Mariette, Christophe ;
Piessen, Guillaume ;
Briez, Nicolas ;
Triboulet, Jean Pierre .
ANNALS OF SURGERY, 2008, 247 (02) :365-371
[28]   Hybrid minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicenter, open-label, randomized phase III controlled trial, the MIRO trial [J].
Mariette, Christophe ;
Meunier, Bernard ;
Pezet, Denis ;
Dalban, Cecile ;
Collet, Denis ;
Thomas, Pascal-Alexandre ;
Brigand, Cecile ;
Perniceni, Thierry ;
Carrere, Nicolas ;
Bonnetain, Franck ;
Piessen, Guillaume .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
[29]   Self-Expanding Covered Metallic Stent as a Bridge to Surgery in Esophageal Cancer: Impact on Oncologic Outcomes [J].
Mariette, Christophe ;
Gronnier, Caroline ;
Duhamel, Alain ;
Mabrut, Jean-Yves ;
Bail, Jean-Pierre ;
Carrere, Nicolas ;
Lefevre, Jeremie H. ;
Meunier, Bernard ;
Collet, Denis ;
Piessen, Guillaume .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2015, 220 (03) :287-296
[30]   Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901 [J].
Mariette, Christophe ;
Dahan, Laetitia ;
Mornex, Francoise ;
Maillard, Emilie ;
Thomas, Pascal-Alexandre ;
Meunier, Bernard ;
Boige, Valerie ;
Pezet, Denis ;
Robb, William B. ;
Le Brun-Ly, Valerie ;
Bosset, Jean-Francois ;
Mabrut, Jean-Yves ;
Triboulet, Jean-Pierre ;
Bedenne, Laurent ;
Seitz, Jean-Francois .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (23) :2416-U201
1234567